
Valpimo 499.5mg/217.5mg Tablet CR
Marketer
Mo-Siki Psychosciences
Salt Composition
Sodium Valproate (499.5mg) + Valproic Acid (217.5mg)
Overview Valpimo 499.5mg/217.5mg Tablet CR
Epileptic seizures, characterized by recurring fits and abnormal brain activity, are effectively managed by the dual-action medication, Valpimo 499.5mg/217.5mg CR tablet. This formulation calms nerve activity, thus preventing seizure episodes. Administered with food, the dosage is determined individually by your physician, potentially escalating gradually until your condition stabilizes. While therapeutic effects may take weeks to manifest, consistent use is crucial. Discontinuation, except under medical guidance, risks increased seizure frequency or exacerbation of bipolar symptoms (if present). Common side effects include nausea and tremors; less frequent reactions involve vomiting, headache, liver complications, and upper abdominal discomfort. Most side effects are transient, but persistent or bothersome symptoms warrant medical attention; mitigating strategies may be available. Prior to commencing treatment, disclose any pre-existing kidney or liver disease, meningitis, depression, or suicidal ideation to your doctor. Comprehensive medication history, including contraceptives, is essential due to potential interactions. Pregnancy and breastfeeding necessitate careful consideration and potential dosage adjustments. Drowsiness or dizziness mandates abstention from driving or cycling. Regular blood tests monitor treatment efficacy. Alcohol consumption should be avoided due to potential side effect intensification. Weight gain is a possibility; a balanced diet, mindful snacking, and regular exercise are recommended. Report any atypical mood shifts, new or worsening depression, or suicidal thoughts or behaviors to your physician immediately.
Primary Ingredients of Valpimo 499.5mg/217.5mg Tablet CR
No text provided. Please provide the text you wish me to rephrase.
Uses of Valpimo 499.5mg/217.5mg Tablet CR
Seizure disorder
Major Benefits of Valpimo 499.5mg/217.5mg Tablet CR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Valpimo 499.5mg/217.5mg CR tablet whole; do not break, crush, or chew it. Administer this medication with food.
Common Side effects of Valpimo 499.5mg/217.5mg Tablet CR:
- Nausea
- Tremors
How to use Valpimo 499.5mg/217.5mg Tablet CR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Valpimo 499.5mg/217.5mg Controlled-Release tablet should be administered with a meal.
How Valpimo 499.5mg/217.5mg Tablet CR works:
Each Valpimo CR tablet (499.5mg/217.5mg) contains a dual anticonvulsant formulation of valproic acid and sodium valproate.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use and Valpimo 499.5mg/217.5mg Tablet CR is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Valpimo tablets (499.5mg/217.5mg) pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Valpimo tablets (499.5mg/217.5mg) are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Taking Valpimo 499.5mg/217.5mg CR tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can likely use Valpimo 499.5mg/217.5mg Tablet CR safely. Existing evidence indicates dose modification may be unnecessary, but medical advice is recommended. Individuals with pre-existing kidney conditions should discuss use with their physician.
LiverCAUTION
Individuals with liver impairment should exercise caution when taking Valpimo 499.5mg/217.5mg CR tablets, as dose modification may be necessary. Medical advice is recommended. Valpimo 499.5mg/217.5mg CR tablets are unsuitable for patients experiencing severe or active liver disease.
What if you forget to take Valpimo 499.5mg/217.5mg Tablet CR :
Should you forget to take a Valpimo 499.5mg/217.5mg CR tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Valpimo 499.5mg/217.5mg Tablet CR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
